med device

How Life Sciences Companies Can Level Up Healthcare Education in Post-COVID Era

The Ultimate Guide to Omnichannel Education

ACTO Emerges as a Leader in Life Sciences Commercialization; Closes Strong Calendar Year 2018 with 184% Revenue Growth and Doubled Customer Base

John Constantine, Senior VP at Orchestrall, Inc: How to Accelerate Drug and Device Launch in the Post-COVID World

ACTO Acquires Scrimmage

ACTO Acquires Scrimmage, Disrupting Life Sciences Learning and Engagement Market

New Era; New Launch Excellence Blueprint for 2021-2022

Episode 7: How is Technology Reshaping the Medical Device Industry?

ACTO Wins Gold Stevie® Award in the Cloud Platform Category in 2019 International Business Awards

My Firsthand Experience with ACTO’s Microlearning, as a Learner
Fighting the Forgetting Curve: The Life Sciences Trainer’s Guide to Microlearning

Life Sciences’ Transformative Journey to Consolidation in 2021 and What to Expect in 2022

Episode 2: How to Accelerate Drug and Device Launch in the Post-COVID World

Channel Partners: Accessibility is the Magic Word


When the Rubber Meets the Road, Don’t Slip

ACTO Kicks Off 2021 with Chart-Topping Growth

For Our Customers: COVID-19 Response Series


ACTO Named One of the 2019 PM360 ELITE 100

What Does ACTO’s Acquisition of CoHealth Mean for Patient Education?

ACTO Integrates Life Sciences Education Platform with Veeva CRM

Implementation Blueprint for Omnichannel Education
Rapid Reskilling in an Ever-Changing Landscape

ACTO Earns Gold at Brandon Hall Technology Awards 2021

ACTO Bolsters Executive Management Team to Meet Significant US Commercial Growth

The LTEN Learning Journey with Kathleen Herndon & Dawn Brehm
Digital Transformation Ideals of Change – Prescription for Pharma and Medical Device Trainers for Rapid Reskilling

ACTO Achieves 158% Year to Date Revenue Growth in 2019 and Has Digitally Transformed Over 50 Life Sciences Companies

ACTO Closes $11.5M Series A Round to Accelerate Virtual Transformation for Life Sciences Companies

ACTO Acquires CoHealth to Open New Frontier in Patient Education

New Era; New Launch Excellence Blueprint for 2021-2022

New Era; New Launch Excellence Blueprint for 2021-2022

The Triple A Initiative: ACTO, Axiom, and AstraZeneca

The Triple A Initiative: ACTO, Axiom, and AstraZeneca
Selling on Clinical Value – Action Plan

Episode 1: Tailoring Your Clinical and Brand Story with Integrity
